treating braf v600e-mutant nsclc with dabrafenib and trametinib
Published 2 years ago • 1.6K plays • Length 2:56Download video MP4
Download video MP3
Similar videos
-
1:26
novel treatment strategies for braf v600e-mutant nsclc
-
6:28
dabrafenib and trametinib in braf-mutated nsclc
-
3:05
dabrafenib and trametinib: a promising combination for the treatment of melanoma
-
1:52
dr. long on dabrafenib/trametinib in braf v600e-mutant melanoma
-
0:59
the success of the dabrafenib and trametinib combination in braf-mutated melanoma
-
3:18
dabrafenib plus trametinib for the treatment of mnsclc
-
2:31
neoadjuvant therapy with trametinib and dabrafenib in high risk resectable braf-mutant melanoma
-
9:16
changing treatment paradigm for braf-mutant nsclc
-
6:25
dabrafenib/trametinib for braf v600e mutation-positive advanced nsclc (bmic-018)
-
0:53
dabrafenib plus trametinib demonstrates benefit in braf-mutant melanoma
-
4:16
combination therapy in braf-mutant nsclc
-
2:19
dr. robert on 5-year analysis of dabrafenib/trametinib in braf v600-mutant melanoma
-
4:08
updates from combi-ad: dabrafenib and trametinib for melanoma
-
2:28
the evolving treatment paradigm for braf v600e-mutant mcrc
-
4:36
practical experience with dabrafenib/trametinib in ncslc
-
3:06
combi-d: phase 3 trial of dabrafenib plus trametinib in braf v600e/k-mutated melanoma
-
2:46
long-term outcomes with dabrafenib plus trametinib in braf v600-mutant melanoma
-
5:55
patient selection in braf-mutant nsclc
-
1:26
dr. nathan on long-term outcomes with dabrafenib/trametinib in braf v600-mutant melanoma